May 31, 2017 11:31 am UTC| Business
COLUMBIA, Md., May 31, 2017 -- EventTracker, a leader in security information and event management (SIEM), today announced that CEO A. N. Ananth will present on the importance of honeynet deception technology in...
Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference
May 31, 2017 11:31 am UTC| Business
WALTHAM, Mass., May 31, 2017 -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that management will present at Jefferies’ 2017 Global Annual...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
ObsEva SA to Attend Jefferies Healthcare Conference in NYC
May 31, 2017 11:13 am UTC| Business
Geneva, Switzerland and Boston, MA - 31 May 2017 - ObsEva SA (Nasdaq: OBSV), a Swiss biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a...
India–US Trade Pact 2026: A New Highway to a USD 500 Billion Partnership